The National Institutes of Health (NIH) Clinical Center awarded a $120,000.00 firm-fixed price purchase order to Bionano Genomics, Inc., a for-profit manufacturer of goods, for the buyout of a proprietary Saphyr System Bionano Optical Genome Mapping (OGM) instrument. This sole-source acquisition is being conducted under the Simplified Acquisition Procedures in Federal Acquisition Regulation (FAR) Part 13, as the total value does not exceed the $250,000.00 Simplified Acquisition Threshold. The Saphyr System is used to detect structural chromosomal aberrations in patient bone marrow samples with hematological malignancies, cancer predisposing disorders, and other complex conditions. The award includes the transfer of ownership, maintenance and support services, software updates and upgrades, and training for the instrument. This contract is not set aside for any specific business type.
Generated 8/3/24, 9:37 AM